BioCentury
ARTICLE | Company News

Merck to acquire SmartCells

December 3, 2010 12:37 AM UTC

Merck & Co. Inc. (NYSE:MRK) will acquire SmartCells Inc. (Beverly, Mass.) in a deal that could be worth over $500 million. SmartCells shareholders will receive an undisclosed upfront cash payment and ...